BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15880054)

  • 1. Prevention of acute vascular rejection by a functionally blocking anti-C5 monoclonal antibody combined with cyclosporine.
    Wang H; Jiang J; Liu W; Kubelik D; Chen G; Gies D; Garcia B; Zhong R; Rother RP
    Transplantation; 2005 May; 79(9):1121-7. PubMed ID: 15880054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement inhibition with an anti-C5 monoclonal antibody prevents hyperacute rejection in a xenograft heart transplantation model.
    Wang H; Rollins SA; Gao Z; Garcia B; Zhang Z; Xing J; Li L; Kellersmann R; Matis LA; Zhong R
    Transplantation; 1999 Dec; 68(11):1643-51. PubMed ID: 10609940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting.
    Wang H; Hosiawa KA; Min W; Yang J; Zhang X; Garcia B; Ichim TE; Zhou D; Lian D; Kelvin DJ; Zhong R
    J Immunol; 2003 Oct; 171(7):3823-36. PubMed ID: 14500684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with a short course of LF 15-0195 and continuous cyclosporin A attenuates acute xenograft rejection in a rat-to-mouse cardiac transplantation model.
    Wang H; Hosiawa KA; Garcia B; Shum JB; Dutartre P; Kelvin DJ; Zhong R
    Xenotransplantation; 2003 Jul; 10(4):325-36. PubMed ID: 12795681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation.
    Kroshus TJ; Rollins SA; Dalmasso AP; Elliott EA; Matis LA; Squinto SP; Bolman RM
    Transplantation; 1995 Dec; 60(11):1194-202. PubMed ID: 8525509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of acute xenograft rejection by short-term treatment with LF15-0195 and monoclonal antibody against CD45RB in a rat-to-mouse cardiac transplantation model.
    Wang H; Hosiawa KA; Garcia B; Shum JB; Dutartre P; Kelvin DJ; Zhong R
    Transplantation; 2003 May; 75(9):1475-81. PubMed ID: 12792500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of terminal complement components in presensitized transplant recipients prevents antibody-mediated rejection leading to long-term graft survival and accommodation.
    Wang H; Arp J; Liu W; Faas SJ; Jiang J; Gies DR; Ramcharran S; Garcia B; Zhong R; Rother RP
    J Immunol; 2007 Oct; 179(7):4451-63. PubMed ID: 17878341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-complement component C5 mAb synergizes with CTLA4Ig to inhibit alloreactive T cells and prolong cardiac allograft survival in mice.
    Raedler H; Vieyra MB; Leisman S; Lakhani P; Kwan W; Yang M; Johnson K; Faas SJ; Tamburini P; Heeger PS
    Am J Transplant; 2011 Jul; 11(7):1397-406. PubMed ID: 21668627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C5 blockade with conventional immunosuppression induces long-term graft survival in presensitized recipients.
    Rother RP; Arp J; Jiang J; Ge W; Faas SJ; Liu W; Gies DR; Jevnikar AM; Garcia B; Wang H
    Am J Transplant; 2008 Jun; 8(6):1129-42. PubMed ID: 18444931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.
    Li J; Xia J; Zhang K; Xu L
    J Surg Res; 2009 Nov; 157(1):81-90. PubMed ID: 19577762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of accelerated rejection of cardiac allografts in sensitized rats by anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy.
    Kupiec-Weglinski JW; Sablinski T; Hancock WW; Di Stefano R; Mariani G; Mix CT; Tilney NL
    Transplantation; 1991 Feb; 51(2):300-5. PubMed ID: 1825240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-LFA-1 alpha reduces the dose of cyclosporin A needed to produce immunosuppression in heterotopic cardiac transplanted rats.
    Harrison PC; Madwed JB
    J Heart Lung Transplant; 1999 Apr; 18(4):279-84. PubMed ID: 10226890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients.
    Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
    Transplantation; 1998 Dec; 66(12):1587-96. PubMed ID: 9884244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance of rat liver allografts induced by short-term selective immunosuppression combining monoclonal antibodies directed against CD25 and CD54 with subtherapeutic cyclosporine.
    Gassel HJ; Otto C; Gassel AM; Meyer D; Steger U; Timmermann W; Ulrichs K; Thiede A
    Transplantation; 2000 Mar; 69(6):1058-67. PubMed ID: 10762208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival.
    Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B
    J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD80/CD86 costimulation regulates acute vascular rejection.
    Hosiawa KA; Wang H; DeVries ME; Garcia B; Liu W; Zhou D; Akram A; Jiang J; Sun H; Cameron MJ; Zhong R; Kelvin DJ
    J Immunol; 2005 Nov; 175(9):6197-204. PubMed ID: 16237117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indefinite allograft survival induced by the combination of multiple donor-specific transfusions, cyclosporine, and an anti-T cell monoclonal antibody in a protocol relevant to cadaveric organ transplantation. The importance of prolonged posttransplant cyclosporine coverage.
    Tchervenkov JI; Cofer BR; Davies C; Alexander JW
    Transplantation; 1995 Mar; 59(6):821-4. PubMed ID: 7701575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunopharmacology of immunosuppression by 15-deoxyspergualin.
    Yuh DD; Morris RE
    Transplantation; 1993 Mar; 55(3):578-91. PubMed ID: 7681226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.